KR101862415B1 - 상승적 항바이러스 조성물 및 이의 용도 - Google Patents

상승적 항바이러스 조성물 및 이의 용도 Download PDF

Info

Publication number
KR101862415B1
KR101862415B1 KR1020127016072A KR20127016072A KR101862415B1 KR 101862415 B1 KR101862415 B1 KR 101862415B1 KR 1020127016072 A KR1020127016072 A KR 1020127016072A KR 20127016072 A KR20127016072 A KR 20127016072A KR 101862415 B1 KR101862415 B1 KR 101862415B1
Authority
KR
South Korea
Prior art keywords
carrageenan
delete delete
pharmaceutical composition
iota
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020127016072A
Other languages
English (en)
Korean (ko)
Other versions
KR20120107970A (ko
Inventor
안드레아스 그라스사우어
에바 프리슐-그라스사우어
크리스티아네 마이어
마리엘르 쾨니히-슈스터
Original Assignee
마리노메드 바이오테크 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44063696&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR101862415(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 마리노메드 바이오테크 아게 filed Critical 마리노메드 바이오테크 아게
Publication of KR20120107970A publication Critical patent/KR20120107970A/ko
Application granted granted Critical
Publication of KR101862415B1 publication Critical patent/KR101862415B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/731—Carrageenans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
KR1020127016072A 2009-12-22 2010-12-17 상승적 항바이러스 조성물 및 이의 용도 Active KR101862415B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28214809P 2009-12-22 2009-12-22
US61/282,148 2009-12-22
PCT/EP2010/007726 WO2011076367A2 (en) 2009-12-22 2010-12-17 Synergistic antiviral composition and use thereof

Publications (2)

Publication Number Publication Date
KR20120107970A KR20120107970A (ko) 2012-10-04
KR101862415B1 true KR101862415B1 (ko) 2018-05-29

Family

ID=44063696

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020127016072A Active KR101862415B1 (ko) 2009-12-22 2010-12-17 상승적 항바이러스 조성물 및 이의 용도

Country Status (21)

Country Link
US (1) US10022449B2 (enExample)
EP (1) EP2515889B1 (enExample)
JP (1) JP5902628B2 (enExample)
KR (1) KR101862415B1 (enExample)
CN (1) CN102652017A (enExample)
AU (1) AU2010335594B2 (enExample)
BR (1) BR112012015202B1 (enExample)
CA (1) CA2779532C (enExample)
CL (1) CL2012001695A1 (enExample)
DK (1) DK2515889T3 (enExample)
EA (1) EA022840B1 (enExample)
ES (1) ES2531367T3 (enExample)
IL (1) IL219552A (enExample)
MX (1) MX2012007166A (enExample)
NZ (1) NZ599839A (enExample)
PL (1) PL2515889T3 (enExample)
PT (1) PT2515889E (enExample)
SG (1) SG181421A1 (enExample)
SI (1) SI2515889T1 (enExample)
WO (1) WO2011076367A2 (enExample)
ZA (1) ZA201202482B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012126777A1 (en) * 2011-03-18 2012-09-27 Marinomed Biotechnologie Gmbh Inhibition of neuraminidase activity
RU2469020C1 (ru) * 2011-11-08 2012-12-10 Александр Васильевич Иващенко (3r,4r,5s)-5-амино-4-ациламино-3-(1-этил-пропокси)-циклогекс-1-ен-карбоновые кислоты, их эфиры и способ применения
RU2520836C1 (ru) * 2013-02-27 2014-06-27 Александр Васильевич Иващенко (3r,4r,5s)-4-амино-5-(2,2-дифторацетиламино)-3-(1-этилпропокси)-циклогекс-1-енкарбоновая кислота и ее эфиры, способ их получения и применения
HUE044329T2 (hu) * 2014-01-22 2019-10-28 Visufarma B V Iota-karragént tartalmazó készítmény vírusos kötõhártya-gyulladás ellen
CN117942405A (zh) * 2016-02-25 2024-04-30 应用生物实验室公司 保护空气传播的病原体和刺激物的组合物和方法
US11304989B2 (en) * 2017-10-06 2022-04-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Peptides for use in the treatment of viral infections
WO2019160261A1 (ko) * 2018-02-14 2019-08-22 (주)나노메디카 항바이러스 처리 방법, 항바이러스 필터, 및 이를 구비한 마스크
KR102316819B1 (ko) * 2018-04-20 2021-10-25 한미약품 주식회사 카라기난을 유효성분으로 포함하는 보존성이 개선된 액상 제제
GB2579600B (en) 2018-12-05 2023-07-05 Byotrol Plc Anti-viral composition
US12245754B2 (en) * 2019-07-03 2025-03-11 Aillis Inc. Pharmaceutical composition for treating influenza virus infections
WO2021184123A1 (en) * 2020-03-18 2021-09-23 Encyt Technologies, Inc. Compositions and methods for the treatment of coronavirus infection and respiratory compromise

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009027057A1 (en) * 2007-08-24 2009-03-05 Marinomed Biotechnologie Gmbh Antiviral composition comprising a sulfated polysaccharide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6593314B1 (en) * 1999-10-19 2003-07-15 Abbott Laboratories Neuraminidase inhibitors
JP2001181188A (ja) * 1999-12-28 2001-07-03 Marine Biotechnol Inst Co Ltd インフルエンザウイルス感染阻害剤
DE602007005697D1 (de) 2006-12-05 2010-05-12 Marinomed Biotechnologie Gmbh Verwendung von carrageenan zur behandlung von rhinovirus-infektionen
EP1930015A1 (en) * 2006-12-05 2008-06-11 Marinomed Biotechnologie GmbH Use of carrageenan for treating rhinovirus infections
CA2673313A1 (en) * 2006-12-18 2008-12-04 Amcol International Virus-interacting layered phyllosilicates and methods of use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009027057A1 (en) * 2007-08-24 2009-03-05 Marinomed Biotechnologie Gmbh Antiviral composition comprising a sulfated polysaccharide

Also Published As

Publication number Publication date
NZ599839A (en) 2014-02-28
SG181421A1 (en) 2012-07-30
PT2515889E (pt) 2015-03-20
AU2010335594A1 (en) 2012-05-24
ES2531367T3 (es) 2015-03-13
PL2515889T3 (pl) 2015-05-29
SI2515889T1 (sl) 2015-04-30
EA022840B1 (ru) 2016-03-31
CL2012001695A1 (es) 2013-03-08
US10022449B2 (en) 2018-07-17
DK2515889T3 (en) 2015-03-02
EA201290373A1 (ru) 2012-11-30
JP2013515022A (ja) 2013-05-02
IL219552A0 (en) 2012-06-28
CA2779532C (en) 2018-05-22
CN102652017A (zh) 2012-08-29
MX2012007166A (es) 2012-07-23
ZA201202482B (en) 2012-12-27
EP2515889A2 (en) 2012-10-31
JP5902628B2 (ja) 2016-04-13
IL219552A (en) 2016-11-30
BR112012015202B1 (pt) 2020-12-08
WO2011076367A2 (en) 2011-06-30
KR20120107970A (ko) 2012-10-04
BR112012015202A2 (pt) 2016-04-05
EP2515889B1 (en) 2014-12-10
WO2011076367A3 (en) 2011-09-01
US20120302522A1 (en) 2012-11-29
AU2010335594B2 (en) 2015-05-21
CA2779532A1 (en) 2011-06-30

Similar Documents

Publication Publication Date Title
KR101862415B1 (ko) 상승적 항바이러스 조성물 및 이의 용도
KR100810872B1 (ko) 감기 치료용 조성물
RU2524304C2 (ru) Применение соли ацетилсалициловой кислоты для лечения вирусных инфекций
CN102448438A (zh) 抗流行性感冒调配物及方法
BRPI0707697A2 (pt) composiÇÕes virucidas contendo metais e usos
KR20110014199A (ko) 비강 비염 치료용 재조합 인간 ｃｃ10 및 이의 조성물
US10052281B2 (en) Local administration-type pharmaceutical for improving dysphagia
CN108472375A (zh) 中重度流感的治疗方法
US20210299077A1 (en) Liposomal reduced glutathione (lrg) in combination with ivermectin for the treatment of covid-19
WO2021191456A1 (en) Compositions for the treatment of a respiratory condition
HK1174835A (en) Synergistic antiviral composition and use thereof
US12485093B2 (en) Composition for use as an antiviral in the form of nasal drops and in nebulisers
EP3906934B1 (en) Application of dalargin for the prevention of viral respiratory infections and prevention of the development of complications during viral respiratory infections
WO2025067689A1 (en) 5-amino-2,3-dihydro-1,4-phthalazinedione for the treatment of infections with an rna virus
WO2022204431A1 (en) Prevention and treatment of coronavirus infection
EA048350B1 (ru) Применение даларгина для профилактики орви и предотвращения развития осложнений при заболеваниях орви
EA023654B1 (ru) Полимерный полисахарид из семян тамариндового дерева для применения в лечении сухого кашля
WO2014199486A1 (ja) 嚥下障害改善用医薬品
HK1200108B (en) Local administration-type pharmaceutical for improving dysphagia

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000